Pfizer COVID vaccine for children under 5 delayed by at least 2 months Ruchika Sharma13 Feb 2022 10:30 AM ISTNew Delhi: A U.S. decision on Pfizer and BioNTech's COVID-19 vaccine for infants and children 6 months through 4 years of age has been postponed for...
Europe medicines watchdog probes link between Pfizer, Moderna COVID vaccine and menstrual changes MD Bureau12 Feb 2022 3:11 PM ISTNew Delhi: Europe's medicines watchdog will probe thousands of reports of women suffering menstrual changes after getting Covid vaccines made by...
COVID vaccines pushes Pfizer beyond expectations in final quarter Ruchika Sharma9 Feb 2022 9:30 AM ISTWashington: COVID-19 vaccine sales boosted Pfizer earnings well past analyst expectations in the final quarter of 2021, but the drugmaker is setting a...
Pfizer India ropes in Pradip Shah as Chairman Ruchika Sharma8 Feb 2022 11:00 AM ISTNew Delhi: Pfizer India has recently announced the appointment of Pradip Shah, Independent Director as the Chairman of the Board of Directors of the...
William Pao appointed as Pfizer Executive Vice President Ruchika Sharma4 Feb 2022 11:24 AM ISTNew York: Pfizer Inc. has recently announced that William Pao, M.D., Ph.D., will join the Company as Executive Vice President and Chief...
Alembic Pharma bags USFDA nod for Fesoterodine Fumarate ER Tablets Ruchika Sharma3 Feb 2022 1:08 PM ISTVadodara: Drug maker, Alembic Pharmaceuticals Limited, has recently announced that the company has received tentative approval from the US Food...
Pfizer, BioNTech begin rolling submission for EUA for COVID vaccine kids below 5 Ruchika Sharma2 Feb 2022 2:09 PM ISTThis application is for authorization of the first two 3 g doses of a planned three-dose primary series in age group of 6 months to 5 years
Pfizer, Ionis Pharma discontinue Vupanorsen Clinical Development Program Ruchika Sharma2 Feb 2022 2:01 PM ISTNew York: Pfizer Inc. and Ionis Pharmaceuticals, Inc. have recently announced the discontinuation of the Pfizer-led clinical development...
Merck COVID drug Molnupiravir last choice for US patients: Report Ruchika Sharma2 Feb 2022 12:07 PM ISTNew Delhi: Merck & Co's new antiviral pill, once touted as a potential game changer for treating COVID-19, is the last choice among four...
Pfizer COVID pill for high-risk patients get EU drug regulator nod Ruchika Sharma30 Jan 2022 9:45 AM ISTNew Delhi: The European Union's drug regulator on Thursday gave the green light to Pfizer Inc's antiviral COVID-19 pill for treating adults at...
Moderna begins trial of Omicron-specific COVID vaccine booster MD Bureau29 Jan 2022 9:00 AM ISTNew York: US drug maker Moderna has started trial of a Covid booster vaccine that specifically targets the Omicron variant, the company has announced....
Hetero Labs, Optimus proposal to launch generic Paxlovid rejected by CDSCO panel: Report Dr. Divya Colin27 Jan 2022 6:10 PM ISTNew Delhi: In a major setback to Hetero Labs and Optimus Pharma, Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
